The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Colchicine Market Research Report 2025
Synopsis
Oral colchicine refers to the formulation of the medication colchicine that is intended for oral administration. Colchicine is a medication derived from the plant Colchicum autumnale, also known as the autumn crocus or meadow saffron. It has been used for centuries as a medicinal agent, particularly in the treatment of gout and other inflammatory conditions.
Oral colchicine is available in the form of tablets or capsules, and it is typically taken by mouth. The medication is rapidly absorbed in the gastrointestinal tract and enters the bloodstream to exert its effects. Colchicine works by inhibiting inflammation and reducing the buildup of uric acid crystals in the joints, which is the underlying cause of gout.
Global Oral Colchicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Colchicine market research.
Key manufacturers engaged in the Oral Colchicine industry include Hikma Pharmaceuticals, Takeda Pharmaceuticals, Viatris, ROMEG Therapeutics, Major Pharmaceuticals, Zydus Pharmaceuticals, Par Pharmaceuticals and KPC Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Oral Colchicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Oral Colchicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Colchicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Hikma Pharmaceuticals
Takeda Pharmaceuticals
Viatris
ROMEG Therapeutics
Major Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceuticals
KPC Pharmaceuticals
Segment by Type
Oral Tablet
Oral Capsule
Oral Solution
Segment by Application
Gout
Familial Mediterranean Fever (FMF)
Pericarditis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Colchicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Oral colchicine refers to the formulation of the medication colchicine that is intended for oral administration. Colchicine is a medication derived from the plant Colchicum autumnale, also known as the autumn crocus or meadow saffron. It has been used for centuries as a medicinal agent, particularly in the treatment of gout and other inflammatory conditions.
Oral colchicine is available in the form of tablets or capsules, and it is typically taken by mouth. The medication is rapidly absorbed in the gastrointestinal tract and enters the bloodstream to exert its effects. Colchicine works by inhibiting inflammation and reducing the buildup of uric acid crystals in the joints, which is the underlying cause of gout.
Global Oral Colchicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Colchicine market research.
Key manufacturers engaged in the Oral Colchicine industry include Hikma Pharmaceuticals, Takeda Pharmaceuticals, Viatris, ROMEG Therapeutics, Major Pharmaceuticals, Zydus Pharmaceuticals, Par Pharmaceuticals and KPC Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Oral Colchicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Oral Colchicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Colchicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Hikma Pharmaceuticals
Takeda Pharmaceuticals
Viatris
ROMEG Therapeutics
Major Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceuticals
KPC Pharmaceuticals
Segment by Type
Oral Tablet
Oral Capsule
Oral Solution
Segment by Application
Gout
Familial Mediterranean Fever (FMF)
Pericarditis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Colchicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Colchicine Market Overview
1.1 Product Overview and Scope of Oral Colchicine
1.2 Oral Colchicine Segment by Type
1.2.1 Global Oral Colchicine Market Value Comparison by Type (2023-2029)
1.2.2 Oral Tablet
1.2.3 Oral Capsule
1.2.4 Oral Solution
1.3 Oral Colchicine Segment by Application
1.3.1 Global Oral Colchicine Market Value by Application: (2023-2029)
1.3.2 Gout
1.3.3 Familial Mediterranean Fever (FMF)
1.3.4 Pericarditis
1.3.5 Others
1.4 Global Oral Colchicine Market Size Estimates and Forecasts
1.4.1 Global Oral Colchicine Revenue 2018-2029
1.4.2 Global Oral Colchicine Sales 2018-2029
1.4.3 Global Oral Colchicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Colchicine Market Competition by Manufacturers
2.1 Global Oral Colchicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Colchicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Colchicine Average Price by Manufacturers (2018-2023)
2.4 Global Oral Colchicine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Colchicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Colchicine, Product Type & Application
2.7 Oral Colchicine Market Competitive Situation and Trends
2.7.1 Oral Colchicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Colchicine Players Market Share by Revenue
2.7.3 Global Oral Colchicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Colchicine Retrospective Market Scenario by Region
3.1 Global Oral Colchicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Colchicine Global Oral Colchicine Sales by Region: 2018-2029
3.2.1 Global Oral Colchicine Sales by Region: 2018-2023
3.2.2 Global Oral Colchicine Sales by Region: 2024-2029
3.3 Global Oral Colchicine Global Oral Colchicine Revenue by Region: 2018-2029
3.3.1 Global Oral Colchicine Revenue by Region: 2018-2023
3.3.2 Global Oral Colchicine Revenue by Region: 2024-2029
3.4 North America Oral Colchicine Market Facts & Figures by Country
3.4.1 North America Oral Colchicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Colchicine Sales by Country (2018-2029)
3.4.3 North America Oral Colchicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Colchicine Market Facts & Figures by Country
3.5.1 Europe Oral Colchicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Colchicine Sales by Country (2018-2029)
3.5.3 Europe Oral Colchicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Colchicine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Colchicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Colchicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Colchicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Colchicine Market Facts & Figures by Country
3.7.1 Latin America Oral Colchicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Colchicine Sales by Country (2018-2029)
3.7.3 Latin America Oral Colchicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Colchicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Colchicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Colchicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Colchicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Colchicine Sales by Type (2018-2029)
4.1.1 Global Oral Colchicine Sales by Type (2018-2023)
4.1.2 Global Oral Colchicine Sales by Type (2024-2029)
4.1.3 Global Oral Colchicine Sales Market Share by Type (2018-2029)
4.2 Global Oral Colchicine Revenue by Type (2018-2029)
4.2.1 Global Oral Colchicine Revenue by Type (2018-2023)
4.2.2 Global Oral Colchicine Revenue by Type (2024-2029)
4.2.3 Global Oral Colchicine Revenue Market Share by Type (2018-2029)
4.3 Global Oral Colchicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Colchicine Sales by Application (2018-2029)
5.1.1 Global Oral Colchicine Sales by Application (2018-2023)
5.1.2 Global Oral Colchicine Sales by Application (2024-2029)
5.1.3 Global Oral Colchicine Sales Market Share by Application (2018-2029)
5.2 Global Oral Colchicine Revenue by Application (2018-2029)
5.2.1 Global Oral Colchicine Revenue by Application (2018-2023)
5.2.2 Global Oral Colchicine Revenue by Application (2024-2029)
5.2.3 Global Oral Colchicine Revenue Market Share by Application (2018-2029)
5.3 Global Oral Colchicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hikma Pharmaceuticals
6.1.1 Hikma Pharmaceuticals Corporation Information
6.1.2 Hikma Pharmaceuticals Description and Business Overview
6.1.3 Hikma Pharmaceuticals Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hikma Pharmaceuticals Oral Colchicine Product Portfolio
6.1.5 Hikma Pharmaceuticals Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Corporation Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Takeda Pharmaceuticals Oral Colchicine Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Corporation Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Viatris Oral Colchicine Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 ROMEG Therapeutics
6.4.1 ROMEG Therapeutics Corporation Information
6.4.2 ROMEG Therapeutics Description and Business Overview
6.4.3 ROMEG Therapeutics Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ROMEG Therapeutics Oral Colchicine Product Portfolio
6.4.5 ROMEG Therapeutics Recent Developments/Updates
6.5 Major Pharmaceuticals
6.5.1 Major Pharmaceuticals Corporation Information
6.5.2 Major Pharmaceuticals Description and Business Overview
6.5.3 Major Pharmaceuticals Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Major Pharmaceuticals Oral Colchicine Product Portfolio
6.5.5 Major Pharmaceuticals Recent Developments/Updates
6.6 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Corporation Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zydus Pharmaceuticals Oral Colchicine Product Portfolio
6.6.5 Zydus Pharmaceuticals Recent Developments/Updates
6.7 Par Pharmaceuticals
6.6.1 Par Pharmaceuticals Corporation Information
6.6.2 Par Pharmaceuticals Description and Business Overview
6.6.3 Par Pharmaceuticals Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Par Pharmaceuticals Oral Colchicine Product Portfolio
6.7.5 Par Pharmaceuticals Recent Developments/Updates
6.8 KPC Pharmaceuticals
6.8.1 KPC Pharmaceuticals Corporation Information
6.8.2 KPC Pharmaceuticals Description and Business Overview
6.8.3 KPC Pharmaceuticals Oral Colchicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 KPC Pharmaceuticals Oral Colchicine Product Portfolio
6.8.5 KPC Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Colchicine Industry Chain Analysis
7.2 Oral Colchicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Colchicine Production Mode & Process
7.4 Oral Colchicine Sales and Marketing
7.4.1 Oral Colchicine Sales Channels
7.4.2 Oral Colchicine Distributors
7.5 Oral Colchicine Customers
8 Oral Colchicine Market Dynamics
8.1 Oral Colchicine Industry Trends
8.2 Oral Colchicine Market Drivers
8.3 Oral Colchicine Market Challenges
8.4 Oral Colchicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
